Back to search
FDAFDA · Food and drugs·Recall number D-0034-2026

Olopatadine Hydrochloride Ophthalmic Solution USP 0.1 %, 5 mL (0.17 FL OZ) bottles, Manufactured for: SOLA PHARMACEUTICALS LLC, Baton Rouge, LA 70810, NDC 70512-0520-05

Published October 29, 2025 · Recall initiated: October 9, 2025

Summary

FDA records drug Class II recall D-0034-2026, published October 29, 2025 and initiated October 9, 2025. Recalling firm: USV Private Limited; Status: Ongoing; Reported quantity: 8,952 bottles; Lot: Lot #: 35000409, Exp. Date 01/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: The result for 'Any individual unspecified impurity' exceeds the specification limit.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
USV Private Limited
Distributor
Nationwide within the United States
Lot
Lot #: 35000409, Exp. Date 01/2026
Risk classification
Class II
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was Olopatadine Hydrochloride Ophthalmic Solution USP 0.1 %, 5 mL (0.17 FL OZ) bottles, Manufactured for: SOLA PHARMACEUTICALS LLC, Baton Rouge, LA 70810, NDC 70512-0520-05 recalled?

Yes. FDA published recall D-0034-2026 on October 29, 2025. Reported hazard: Failed Impurities/Degradation Specifications: The result for 'Any individual unspecified impurity' exceeds the specification limit.

What should I do if I have this product?

Voluntary: Firm initiated · Letter